PD-1/CTLA-4
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) (NCT07289997) | Hebei Medical University Fourth Hospital | 2025-09-28 |
Track PD-1/CTLA-4 automatically
Every clearance here is in the API, with alerts when new ones post.